ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.00%
Dow Jones
40,003.59
0.00%
US Dollar vs MXN
16.62255
0.13%
Brent Oil
83.385
-0.25%
Bitcoin
66,811.96
0.98%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSX
  6. Valeo Pharma Inc (VPH)

  7. Valeo Pharma Inc (VPH) Noticias

VPH

Valeo Pharma (VPH)

Valeo Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSX:VPH
FechaHoraFuenteTítuloSímboloCompañía
25/04/202416:55PR Newswire (Canada)VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERSTSX:VPHValeo Pharma Inc
09/04/202406:00PR Newswire (Canada)VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCETSX:VPHValeo Pharma Inc
22/03/202406:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORSTSX:VPHValeo Pharma Inc
14/03/202416:29PR Newswire (Canada)VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTSTSX:VPHValeo Pharma Inc
07/03/202406:00PR Newswire (Canada)VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
13/02/202406:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES BOARD OF DIRECTORS CHANGESTSX:VPHValeo Pharma Inc
02/02/202416:03PR Newswire (Canada)VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LPTSX:VPHValeo Pharma Inc
29/01/202416:48PR Newswire (Canada)VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL YEAR 2023TSX:VPHValeo Pharma Inc
22/01/202406:00PR Newswire (Canada)VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
20/11/202306:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND COST REDUCTION INITIATIVESTSX:VPHValeo Pharma Inc
07/11/202306:15PR Newswire (Canada)VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORSTSX:VPHValeo Pharma Inc
04/10/202306:00PR Newswire (Canada)VALEO PHARMA MAKES THE LIST OF THE GLOBE AND MAIL'S FIFTH-ANNUAL RANKING OF CANADA'S TOP GROWING COMPANIESTSX:VPHValeo Pharma Inc
27/09/202306:00PR Newswire (Canada)VALEO PHARMA ENTERS INTO $5 MILLION CREDIT FACILITY AGREEMENT WITH ACCORD FINANCIAL INC.TSX:VPHValeo Pharma Inc
27/09/202306:00PR Newswire (Canada)VALEO PHARMA CONCLUT UNE ENTENTE DE FACILITÉ DE CRÉDIT DE 5 MILLIONS $ AVEC ACCORD FINANCIAL INC.TSX:VPHValeo Pharma Inc
13/09/202319:01PR Newswire (Canada)VALEO PHARMA ANNONCE DES REVENUS RECORDS POUR LE TROISIÈME TRIMESTRE DE 2023TSX:VPHValeo Pharma Inc
13/09/202318:44PR Newswire (Canada)VALEO PHARMA REPORTS RECORD THIRD QUARTER 2023 REVENUESTSX:VPHValeo Pharma Inc
07/09/202306:00PR Newswire (Canada)VALEO PHARMA TO HOST THIRD QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
31/08/202318:11PR Newswire (Canada)Investissement Québec conclut un placement privé dans Valeo Pharma Inc.TSX:VPHValeo Pharma Inc
31/08/202317:27PR Newswire (Canada)VALEO PHARMA CONCLUT UN FINANCEMENT DE 4,5 MILLIONS $TSX:VPHValeo Pharma Inc
31/08/202317:10PR Newswire (Canada)VALEO PHARMA CLOSES $4.5 MILLION FINANCINGTSX:VPHValeo Pharma Inc
22/06/202306:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTSTSX:VPHValeo Pharma Inc
07/06/202306:00PR Newswire (Canada)VALEO PHARMA TO HOST SECOND QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
25/05/202306:00PR Newswire (Canada)VALEO PHARMA PROVIDING GUIDANCE OF RECORD REVENUES FOR THE SECOND QUARTER 2023TSX:VPHValeo Pharma Inc
28/04/202306:43PR Newswire (Canada)VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS AND COMMITTEE APPOINTMENTSTSX:VPHValeo Pharma Inc
19/04/202306:00PR Newswire (Canada)VALEO PHARMA TO PRESENT AT THE 2023 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCETSX:VPHValeo Pharma Inc
15/03/202316:00PR Newswire (Canada)VALEO PHARMA REPORTS RECORD QUARTERLY REVENUES FOR THE FIRST QUARTER 2023TSX:VPHValeo Pharma Inc
09/03/202306:00PR Newswire (Canada)VALEO PHARMA TO HOST FIRST QUARTER 2023 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
07/02/202306:00PR Newswire (Canada)VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ONSTRYV® IN QUEBECTSX:VPHValeo Pharma Inc
26/01/202306:00PR Newswire (Canada)VALEO PHARMA ANNOUNCES FILING OF A NEW DRUG SUBMISSION-COVID 19 WITH HEALTH CANADA FOR SABIZABULIN FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTSTSX:VPHValeo Pharma Inc
25/01/202308:38PR Newswire (Canada)VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2022 RESULTS CONFERENCE CALL / WEBCASTTSX:VPHValeo Pharma Inc
 Showing the most relevant articles for your search:TSX:VPH

Su Consulta Reciente

NYSE
PMT-C
PennyMac Mortgage Invest...
BIT
P21183
NLBNPIT21183 20991231 20...
TG
7SPB
SPI Electricity and Gas
NYSE
RCFA
Perception Capital Corp IV
BITMOT
923302
Eu Sure Bond Tf 1,125% G...
USOTC
DMKPQ
DMK Pharmaceuticals (PK)
NYSE
PYS
Merrill Lynch Depositor
BIT
P1VT38
NLBNPIT1VT38 20991231 28...
COIN
LDCUSD
USOTC
EMUSF
Electric Metals USA (QB)
TG
A28WYK
CRH
TG
A1ZPB6
Sanofi
BIT
P20O04
NLBNPIT20O04 20240528 90
BIT
P1XHM3
NLBNPIT1XHM3 20240621 1.8
COIN
SFUSDUSD
StableFund USD
EU
BE0390104678
Brussels Capital Region ...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados